ANI Pharma (ANIP) Tops Q2 EPS by 34c; Boosts FY16 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharma (ANIP) Tops Q2 EPS by 34c; Boosts FY16 Outlook

Guggenheim Raises Price Target on ANI Pharma (ANIP) Following 2Q Earnings Report

August 4, 2016 3:49 PM EDT

Guggenheim reiterated a Buy rating on ANI Pharmaceuticals (NASDAQ: ANIP), and raised the price target to $80.00 (from $65.00), following the company's 2Q earnings report. ANIP reported adjusted diluted EPS of $1.11, $0.31 higher than consensus estimates. ANIP raised its '16 EPS guidance range from $3.54-$3.91 to... More